tiprankstipranks
Medivir AB (GB:0GP7)
LSE:0GP7
UK Market
0GP7
Medivir AB
RESEARCH TOOLSreports

Medivir AB (0GP7) Financial Statements

0 Followers

Medivir AB Financial Overview

Medivir AB's market cap is currently kr1.14B. The company's EPS TTM is kr-0.035; its P/E ratio is -5.09; and it has a dividend yield of 4.35%. Medivir AB is scheduled to report earnings on August 20, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit--$ 13.95M--
Operating Income$ -88.61M$ -64.40M$ -55.68M$ -128.59M$ -351.03M
EBITDA$ -85.27M$ -59.03M$ -37.64M$ -114.93M$ -324.16M
Net Income$ -88.77M$ -63.13M$ -42.62M$ -123.44M$ -350.31M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 234.20M$ 335.82M$ 191.46M$ 293.46M$ 419.35M
Total Debt$ 15.51M$ 14.02M$ 16.49M$ 43.88M$ 0.00
Net Debt$ -101.92M$ -207.15M$ -53.52M$ -90.63M$ -286.28M
Total Liabilities$ 41.41M$ 54.68M$ 49.56M$ 109.01M$ 111.75M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -102.20M$ -48.73M$ -60.74M$ -149.69M$ -325.47M
Operating Cash Flow$ -101.82M$ -48.73M$ -58.05M$ -148.25M$ -318.63M
Investing Cash Flow
Financing Cash Flow

Medivir AB Earnings and Revenue History

Income Statement >

Medivir AB Debt to Assets

Balance Sheet >

Medivir AB Cash Flow

Cash Flow >

Medivir AB Forecast EPS vs Actual EPS

Earnings >